Platelet-derived Growth Factor and Transforming Growth Factor-beta Enhance Tissue Repair Activities by Unique Mechanisms
Overview
Affiliations
Platelet-derived growth factor (PDGF) and transforming growth factor-beta (TGF-beta) markedly potentiate tissue repair in vivo. In the present experiments, both in vitro and in vivo responses to PDGF and TGF-beta were tested to identify mechanisms whereby these growth factors might each enhance the wound-healing response. Recombinant human PDGF B-chain homodimers (PDGF-BB) and TGF-beta 1 had identical dose-response curves in chemotactic assays with monocytes and fibroblasts as the natural proteins from platelets. Single applications of PDGF-BB (2 micrograms, 80 pmol) and TGF-beta 1 (20 micrograms, 600 pmol) were next applied to linear incisions in rats and each enhanced the strength required to disrupt the wounds at 5 d up to 212% of paired control wounds. Histological analysis of treated wounds demonstrated an in vivo chemotactic response of macrophages and fibroblasts to both PDGF-BB and to TGF-beta 1 but the response to TGF-beta 1 was significantly less than that observed with PDGF-BB. Marked increases of procollagen type I were observed by immunohistochemical staining in fibroblasts in treated wounds during the first week. The augmented breaking strength of TGF-beta 1 was not observed 2 and 3 wk after wounding. However, the positive influence of PDGF-BB on wound breaking strength persisted through the 7 wk of testing. Furthermore, PDGF-BB-treated wounds had persistently increased numbers of fibroblasts and granulation tissue through day 21, whereas the enhanced cellular influx in TGF-beta 1-treated wounds was not detectable beyond day 7. Wound macrophages and fibroblasts from PDGF-BB-treated wounds contained sharply increased levels of immunohistochemically detectable intracellular TGF-beta. Furthermore, PDGF-BB in vitro induced a marked, time-dependent stimulation of TGF-beta mRNA levels in cultured normal rat kidney fibroblasts. The results suggest that TGF-beta transiently attracts fibroblasts into the wound and may stimulate collagen synthesis directly. In contrast, PDGF is a more potent chemoattractant for wound macrophages and fibroblasts and may stimulate these cells to express endogenous growth factors, including TGF-beta, which, in turn, directly stimulate new collagen synthesis and sustained enhancement of wound healing over a more prolonged period of time.
Human platelet lysate: a potential therapeutic for intracerebral hemorrhage.
Qiu D, Wang L, Wang L, Dong Y Front Neurosci. 2025; 18:1517601.
PMID: 39881806 PMC: 11774881. DOI: 10.3389/fnins.2024.1517601.
An Update on Molecular Mechanisms of Scarring-A Narrative Review.
Kohlhauser M, Mayrhofer M, Kamolz L, Smolle C Int J Mol Sci. 2024; 25(21).
PMID: 39519131 PMC: 11546163. DOI: 10.3390/ijms252111579.
"Therapeutic advancements in nanomedicine: The multifaceted roles of silver nanoparticles".
Karunakar K, Cheriyan B, R K, M G, B A Biotechnol Notes. 2024; 5:64-79.
PMID: 39416696 PMC: 11446369. DOI: 10.1016/j.biotno.2024.05.002.
Lee J, Park J, Chang Y, Yoon J, Chung S Sci Rep. 2024; 14(1):17632.
PMID: 39085278 PMC: 11292015. DOI: 10.1038/s41598-024-67572-y.
Cellular and microenvironmental cues that promote macrophage fusion and foreign body response.
Stewart C, Hook A, Zelzer M, Marlow M, Piccinini A Front Immunol. 2024; 15:1411872.
PMID: 39034997 PMC: 11257916. DOI: 10.3389/fimmu.2024.1411872.